A TLR7 Agonist Inhibits Bronchoconstriction In Vivo and In Vitro.

被引：0
作者：
Kaufman, E. H. [1 ]
Fryer, A. D. [1 ]
Jacoby, D. B. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2811
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A surprising role for TLR7
    Lederman, Michael M.
    NATURE IMMUNOLOGY, 2015, 16 (01) : 8 - 9
  • [32] IN VIVO LIVER EXPRESSION OF TLR2, TLR3 AND TLR7 IN CHRONIC HEPATITIS C
    Tarantino, G.
    Di Cristina, A.
    Pipitone, R.
    Almasio, P. L.
    Di Vita, G.
    Craxi, A.
    Grimaudo, S.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2013, 27 (01) : 233 - 239
  • [33] The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)
    Fidock, M. D.
    Souberbielle, B. E.
    Laxton, C.
    Rawal, J.
    Delpuech-Adams, O.
    Corey, T. P.
    Colman, P.
    Kumar, V.
    Cheng, J. B.
    Wright, K.
    Srinivasan, S.
    Rana, K.
    Craig, C.
    Horscroft, N.
    Perros, M.
    Westby, M.
    Webster, R.
    van der Ryst, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 821 - 829
  • [34] C/EBPα inhibits erythroid development and differentiation in vivo and in vitro.
    Suh, HC
    Ortiz, M
    Gooya, J
    Renn, K
    Friedman, AD
    Johnson, P
    Keller, J
    BLOOD, 2003, 102 (11) : 342A - 342A
  • [35] Enhancement of antitumor activity of DSP-6434, a novel TLR7 agonist through reduction of TLR tolerance
    Koga-Yamakawa, Erina
    Murata, Masashi
    Dovedi, Simon J.
    Wilkinson, Robert W.
    Umehara, Hiroki
    Sugaru, Eiji
    Hirose, Yuko
    Harada, Hideyuki
    Robinson, David T.
    Jewsbury, Philip J.
    Yamamoto, Setsuko
    Li, Chiang J.
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Colloidal TLR7/8 agonist conjugated nanoparticles for safe and synergistic cancer immunotherapy
    De Geest, Bruno
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [37] The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine
    Donadei, Agnese
    Balocchi, Cristiana
    Mancini, Francesca
    Proietti, Daniela
    Gallorini, Simona
    O'Hagan, Derek T.
    D'Oro, Ugo
    Berti, Francesco
    Baudner, Barbara C.
    Adamo, Roberto
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 107 : 110 - 119
  • [38] Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
    Borducchi, Erica N.
    Liu, Jinyan
    Nkolola, Joseph P.
    Cadena, Anthony M.
    Yu, Wen-Han
    Fischinger, Stephanie
    Broge, Thomas
    Abbink, Peter
    Mercado, Noe B.
    Chandrashekar, Abishek
    Jetton, David
    Peter, Lauren
    McMahan, Katherine
    Moseley, Edward T.
    Bekerman, Elena
    Hesselgesser, Joseph
    Li, Wenjun
    Lewis, Mark G.
    Alter, Galit
    Geleziunas, Romas
    Barouch, Dan H.
    NATURE, 2018, 563 (7731) : 360 - +
  • [39] A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
    Chi, Huju
    Hao, Yue
    Wang, Xia
    Tang, Li
    Deng, Yongqiang
    Chen, Xianxiong
    Gao, Feng
    Sha, Ou
    Jin, Guangyi
    CELLS, 2022, 11 (13)
  • [40] Thiostrepton inhibits psoriasis-like inflammation induced by TLR7, TLR8, and TLR9
    Lai, Chao-Yang
    Yeh, Da-Wei
    Lu, Chih-Hao
    Liu, Yi-Ling
    Huang, Li-Rung
    Kao, Cheng-Yuan
    Chen, Huan-Yuan
    Huang, Chi-Ying F.
    Chang, Chung-Hsing
    Luo, Yunping
    Xiang, Rong
    Chuang, Tsung-Hsien
    JOURNAL OF IMMUNOLOGY, 2016, 196
12345